Momentum Stocks

Bear of the Day: Cubic Corp (CUB)

Cubic Corp ( CUB ) has been sailing through choppy waters for several years, and the newest hurdle the company is facing is the increased strength of the U.S. dollar, which has added pressure to the company’s income statement. This net income problem was further exasperated by declines in Joint Readiness Training Center exercises in the fourth quarter 2015. […]

Momentum Stocks

Bull of the Day: Dycom Inds (DY)

Dycom Industries ( DY ) continues to be at the forefront of the fiber-based broadband revolution, and has significantly beaten the Zacks Consensus Earnings estimate for 7 consecutive quarters. These big beats are driven by their top 5 customers, who are the leading fiber optic service companies in America. These major companies like Comcast, and AT&T have increased their fiber to home, and fiber to small business services, which have also accelerated their deployment of fiber-based broadband. […]

Mergers & Acquisitions

PolyOne Expands Specialty Offerings with Acquisition of Magenta Master Fibers

PolyOne Expands Specialty Offerings with Acquisition of Magenta Master Fibers – Specialty acquisition broadens solutions portfolio of colorant and additives technologies for fiber applications – Extends PolyOne’s existing reach into strategic end markets such as transportation and consumer goods – Accelerates global growth with local manufacturing and commercial presence in Europe and Asia PR Newswire CLEVELAND, Dec. 9, 2015 CLEVELAND , Dec. 9, 2015 /PRNewswire/ — PolyOne Corporation (NYSE: POL), a premier global provider of specialized polymer materials, services and solutions, today announced the acquisition of Magenta Master Fibers (Magenta), an innovative developer of specialty solid color concentrates for the global fiber industry […]

Stock Analysts

AXIS Capital Up on Share Buyback, Dividend Hike Approval

The board of directors of AXIS Capital Holdings Limited AXS has approved a new $750 million share repurchase program and a 21% hike in its quarterly dividend. Share price gained about 0.9% in yesterday’s trading session, reflecting investor optimism on prudent capital deployment that will in turn enhance shareholder value. The new program authorizes the insurer to buy back $750 million worth shares through Dec 2016 […]

Stock Analysts

5 Excellent Income Stocks to Buy Now

Is now the time for dividend investing? While the dividend investing style is almost always overlooked, it still has a place in many portfolios even though many consider it a 'boring' way to growth wealth in a portfolio. Sure investors often prefer growth securities that are increasing earnings or revenues, or securities with value metrics such as low PEs and modest debt levels, but now could actually be an interesting time for dividend investing. […]

Stock Analysts

AbbVie Presents Data on Imbruvica and Venetoclax at ASH

AbbVie Inc. ABBV presented encouraging results on Imbruvica and its experimental multiple myeloma candidate, venetoclax, at the annual meeting of the American Society of Hematology (ASH). Presented Multiple Data on Imbruvica AbbVie announced that results from the phase III study (RAY) showed Imbruvica significantly prolonged progression-free survival (the primary endpoint) and improved overall response rates (ORR) – a key secondary endpoint – in patients with relapsed or refractory mantle cell lymphoma (MCL) compared with Torisel (temsirolimus) […]

Stock Analysts

Medtronic: Balanced Q2 Growth, Covidien Integration on Track

On Dec 7, 2015, we issued an updated research report on Medtronic plc MDT . The combined company (post the legacy Medtronic-Covidien merger) handily outpaced the Zacks Consensus Estimate of both earnings and revenues in the second quarter of fiscal 2016. The consolidated company demonstrated strong segmental performances reflecting successful integration and achievement of synergy targets. […]

Stock Analysts

Is Netflix (NFLX) Keen on Expanding into the Sports Market?

At the UBS 43rd Annual Global Media and Communications Conference held yesterday, online streaming giant Netflix, Inc . NFLX maintained its “never say never” stand on entering the sports market. Netflix chief content officer, Ted Sarandos said that it is not that the company will never get into sports but maintained management’s earlier stance that foraying into live sports and news is not really attractive […]

Stock Analysts

Kite Pharma Begins Study on KTE-C19, Presents Data at ASH

Kite Pharma, Inc. KITE announced that it has initiated a phase I/II study (ZUMA-4) on its lead pipeline candidate, KTE-C19, for the treatment of pediatric and young adults suffering from relapsed or refractory acute lymphoblastic leukemia (r/r ALL). The single-arm, open-label, multi-center study, which will enroll 75 patients, will be conducted in patients with ALL whose disease is refractory to or has relapsed following standard chemotherapy or hematopoietic stem cell transplantation […]